Mechanism of total flavonoids from Ampelopsis grossedentata against gouty arthritis based on multi-level interactive network and in vivo experimental validation.
10.19540/j.cnki.cjcmm.20220223.701
- Author:
Jia-Chuan LI
1
;
Si-Ying LI
1
;
Qin SONG
1
;
Er-Xiu MA
2
;
Mu-Karan AIMAIJIANG
1
Author Information
1. College of Pharmacy, Southwest Minzu University Chengdu 610041, China.
2. College of Pharmacy, Southwest Minzu University Chengdu 610041, China College of Forestry and Health, the Open University of Sichuan Chengdu 610075, China.
- Publication Type:Journal Article
- Keywords:
gouty arthritis;
mechanism of action;
network pharmacology;
total flavonoids from Ampelopsis grossedentata
- MeSH:
Ampelopsis/chemistry*;
Animals;
Arthritis, Gouty/drug therapy*;
Flavonoids/therapeutic use*;
Interleukin-1beta/metabolism*;
Interleukin-6/metabolism*;
Myeloid Differentiation Factor 88/metabolism*;
NF-kappa B/metabolism*;
NLR Proteins/metabolism*;
Rats;
Toll-Like Receptor 4/metabolism*;
Tumor Necrosis Factor-alpha/metabolism*;
Uric Acid;
Xanthine Oxidase
- From:
China Journal of Chinese Materia Medica
2022;47(17):4733-4743
- CountryChina
- Language:Chinese
-
Abstract:
The present study investigated the mechanism of total flavonoids from Ampelopsis grossedentata(AGTF) against gouty arthritis(GA) by network pharmacology and experimental validation. The main active ingredients and targets of AGTF, as well as disease targets, were screened out using relevant databases and literature data. The "protein-protein interaction"(PPI) network and "drug-ingredient-target-pathway" network were constructed, and the potential targets and mechanism of AGTF against GA were predicted. The hyperuricemia(HUA) combined with GA model was induced in rats. The gait behaviors of rats were scored, and ankle swelling degree was observed. The uric acid(UA) level and xanthine oxidase(XOD) activity in the rat serum were detected, and the levels of interleukin-1β(IL-1β), interleukin-6(IL-6), and tumor necrosis factor-α(TNF-α) were measured. The protein expression of toll-like receptor 4(TLR4), myeloid differentiation factor 88(MyD88), and nuclear factor-kappa B(NF-κB) in the synovial tissues of the rat ankle joint was determined by immunohistochemistry. Ten active ingredients of AGTF and 73 candidate targets of AGTF against GA were screened out by network pharmacology. Eighty-six signaling pathways were enriched, including TNF signaling pathway, NF-κB signaling pathway, TLR signaling pathway, Nod-like receptor signaling pathway, and purine metabolism signaling pathway, which were closely related to AGTF against GA. Animal experimental results showed that AGTF could effectively improve the abnormal gait behaviors of GA rats, relieve ankle inflammation, and reduce ankle joint swelling. In addition, AGTF could significantly reduce UA level, inhibit XOD activity, decrease TNF-α, IL-6, and IL-1β content, and down-regulate the expression of TLR4, MyD88, and NF-κB in ankle synovial tissues(P<0.05, P<0.01). The results of network pharmacology and experimental validation are consistent, indicating that AGTF exerts its therapeutic effect on GA by regulating UA metabolism, improving abnormal UA level, reducing the release of inflammatory factors, and regulating immunity and the TLR4/MyD88/NF-κB inflammatory pathway.
